Autifony Therapeutics Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Autifony Therapeutics is a clinical-stage biotechnology company focused on developing medicines for rare genetic central nervous system disorders. It employs an ion-channel focused drug discovery platform to identify therapeutic candidates. The company is based in Stevenage, England, and traces its origins to a 2011 spin-out from GSK. It operates as a relatively small organization within the biotech sector. Within the biotechnology field, Autifony positions itself around rare CNS disorders where novel therapies are scarce. In 2023 the company disclosed an exclusive global licensing agreement with Jazz Pharmaceuticals, indicating a strategic external collaboration.